South & Central America Aesthetic Injectable Devices Market Size and Forecast (2021

List of Tables

The South & Central America aesthetic injectable devices market is projected to grow from US$ 545.2 million in 2024 to US$ 876.3 million by 2031, registering a CAGR of 7.2% during 2025-2031.

Executive Summary & Market Overview:

The market in South & Central America-particularly in Brazil and Argentina-is witnessing steady, moderate growth. This expansion is largely driven by a rising middle class and a younger, appearance-conscious population. Demand continues to favor minimally invasive procedures that deliver effective results with short recovery times, such as botulinum toxin injections and dermal fillers.

Improved healthcare infrastructure and better access to aesthetic services in urban areas are also supporting market penetration. The presence of skilled medical professionals and a growing preference for non-surgical treatments further strengthen regional growth. In addition, ongoing advancements in product safety and longevity are boosting consumer confidence and encouraging wider adoption.

Segmentation Insights:

By product, botulinum toxin dominated the market in 2024, followed by dermal fillers.

Within dermal fillers, hyaluronic acid accounted for the largest share.

By device, pre-filled syringes led the segment.

By application, facial line correction held the largest share.

By age group, individuals aged 31-40 formed the leading segment.

By gender, females dominated the market.

By end user, dermatology clinics accounted for the highest share.

Market Outlook:

A major trend shaping the market is the rise of regenerative aesthetics, which focuses on stimulating the body's natural healing processes for longer-lasting and more natural results. Treatments such as platelet-rich plasma (PRP), biostimulatory fillers, and exosome-based therapies enhance collagen production and improve skin elasticity.

Innovations like Sculptra and technologies such as Morpheus8 are redefining anti-aging treatments by combining collagen stimulation with skin-tightening capabilities. These approaches provide non-surgical solutions that improve skin firmness and texture over time.

As collagen levels naturally decline with age, there is growing interest in treatments that promote long-term skin regeneration. Patients increasingly prefer subtle, natural-looking outcomes, driving demand for bio-stimulating injectables and combination therapies.

Country Insights:

Brazil led the regional market in 2024, supported by a rapidly aging population and strong demand for minimally invasive cosmetic procedures. The country is expected to see a significant rise in its elderly population in the coming decades, which will further drive demand for anti-aging solutions.

Brazil already performs millions of aesthetic procedures annually, with injectable treatments accounting for a substantial share. The popularity of these procedures is linked to their effectiveness, minimal downtime, and increasing consumer preference for non-surgical options.

Additionally, product innovation and collaborations among industry players are accelerating market growth. New certifications, advanced filler technologies, and product launches highlight the region's growing focus on high-quality, science-driven aesthetic solutions.

Key Market Players:

Leading companies operating in this market include Merz Pharma GmbH & Co. KGaA, AbbVie Inc., Ipsen SA, Galderma SA, Revance Therapeutics Inc., Evolus Inc., and Hugel Inc., among others. These companies are focusing on innovation, partnerships, and expansion strategies to strengthen their presence in the region.

Product Code: TIPRE00041913

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macroeconomic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country-level data:

4. Aesthetic Injectable Devices Market Landscape

4.2 PEST Analysis
4.3 Global and Regional Average Cost Range, 2024

4. South & Central America Aesthetic Injectable Devices Market - Key Market Dynamics

4.1 Market Drivers
4.2 Market Restraints
4.3 Market Opportunities
4.4 Future Trends
4.5 Impact of Drivers and Restraints:

5. Aesthetic Injectable Devices Market - South & Central America Market Analysis

5.1 South & Central America Aesthetic Injectable Devices Market Revenue (US$ Million), 2024 - 2031
5.2 South & Central America Aesthetic Injectable Devices Market Forecast and Analysis

6. South & Central America Aesthetic Injectable Devices Market Revenue Analysis - by Product

6.1 Dermal Filler
- 6.1.1 Overview
- 6.1.2 Dermal Filler: South & Central America Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
6.2 Botulinum Toxin
- 6.2.1 Overview
- 6.2.2 Botulinum Toxin: South & Central America Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
6.3 Others
- 6.3.1 Overview
- 6.3.2 Others: South & Central America Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)

8. South & Central America Aesthetic Injectable Devices Market Revenue Analysis - by Dermal Fillers

7.1 Calcium Hydroxylapatite
- 7.1.1 Overview
- 7.1.2 Calcium Hydroxylapatite: South & Central America Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.2 Hyaluronic Acid
- 7.2.1 Overview
- 7.2.2 Hyaluronic Acid: South & Central America Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.3 Collagen
- 7.3.1 Overview
- 7.3.2 Collagen: South & Central America Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.4 Poly-L-Lactic Acid
- 7.4.1 Overview
- 7.4.2 Poly-L-Lactic Acid: South & Central America Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.5 Polymethylmethacrylate (PMMA)
- 7.5.1 Overview
- 7.5.2 Polymethylmethacrylate (PMMA): South & Central America Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.6 Fat Fillers
- 7.6.1 Overview
- 7.6.2 Fat Fillers: South & Central America Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.7 Others
- 7.7.1 Overview
- 7.7.2 Others: South & Central America Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)

8. South & Central America Aesthetic Injectable Devices Market Revenue Analysis - by Device

8.1 Microcannulas
- 8.1.1 Overview
- 8.1.2 Microcannulas: South & Central America Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.2 Pre-Filled Syringes
- 8.2.1 Overview
- 8.2.2 Pre-Filled Syringes: South & Central America Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.3 Mesotherapy Guns
- 8.3.1 Overview
- 8.3.2 Mesotherapy Guns: South & Central America Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.4 Others
- 8.4.1 Overview
- 8.4.2 Others: South & Central America Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)

9. South & Central America Aesthetic Injectable Devices Market Revenue Analysis - by Application

9.1 Facial Line Correction
- 9.1.1 Overview
- 9.1.2 Facial Line Correction: South & Central America Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.2 Face Lift
- 9.2.1 Overview
- 9.2.2 Face Lift: South & Central America Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.3 Lip Treatment
- 9.3.1 Overview
- 9.3.2 Lip Treatment: South & Central America Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.4 Anti-Ageing and Wrinkle Treatment
- 9.4.1 Overview
- 9.4.2 Anti-Ageing and Wrinkle Treatment: South & Central America Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.5 Acne and Scar Treatment
- 9.5.1 Overview
- 9.5.2 Acne and Scar Treatment: South & Central America Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.6 Stretch Marks
- 9.6.1 Overview
- 9.6.2 Stretch Marks: South & Central America Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.7 Others
- 9.7.1 Overview
- 9.7.2 Others: South & Central America Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)

10. South & Central America Aesthetic Injectable Devices Market Revenue Analysis - by Age Group

10.1 Up to 30
- 10.1.1 Overview
- 10.1.2 Up to 30: South & Central America Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.2 31-40
- 10.2.1 Overview
- 10.2.2 31-40: South & Central America Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.3 41-50
- 10.3.1 Overview
- 10.3.2 41-50: South & Central America Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.4 51-60
- 10.4.1 Overview
- 10.4.2 51-60: South & Central America Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.5 More Than 60
- 10.5.1 Overview
- 10.5.2 More Than 60: South & Central America Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)

11. South & Central America Aesthetic Injectable Devices Market Revenue Analysis - by Gender

11.1 Female
- 11.1.1 Overview
- 11.1.2 Female: South & Central America Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.2 Male
- 11.2.1 Overview
- 11.2.2 Male: South & Central America Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)

12. South & Central America Aesthetic Injectable Devices Market Revenue Analysis - by End User

12.1 Medical Spas
- 12.1.1 Overview
- 12.1.2 Medical Spas: South & Central America Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.2 Dermatology Clinics
- 12.2.1 Overview
- 12.2.2 Dermatology Clinics: South & Central America Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.3 Hospitals
- 12.3.1 Overview
- 12.3.2 Hospitals: South & Central America Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.4 Others
- 12.4.1 Overview
- 12.4.2 Others: South & Central America Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)

13. South & Central America Aesthetic Injectable Devices Market - Country Analysis

13.1 South & Central America
- 13.1.1 South & Central America Aesthetic Injectable Devices Market Revenue and Forecast and Analysis - by Country
  - 13.1.1.1 South & Central America Aesthetic Injectable Devices Market Revenue and Forecast and Analysis - by Country
  - 13.1.2.2 Brazil: South & Central America Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
    - 13.1.2.2.1 Brazil: South & Central America Aesthetic Injectable Devices Market Share - by Product
    - 13.1.2.2.2 Brazil: South & Central America Aesthetic Injectable Devices Market Share - by Dermal Fillers
    - 13.1.2.2.3 Brazil: South & Central America Aesthetic Injectable Devices Market Share - by Device
    - 13.1.2.2.4 Brazil: South & Central America Aesthetic Injectable Devices Market Share - by Application
    - 13.1.2.2.5 Brazil: South & Central America Aesthetic Injectable Devices Market Share - by Age Group
    - 13.1.2.2.6 Brazil: South & Central America Aesthetic Injectable Devices Market Share - by Gender
    - 13.1.2.2.7 Brazil: South & Central America Aesthetic Injectable Devices Market Share - by End User
  - 13.2.3.3 Argentina: South & Central America Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
    - 13.2.3.3.1 Argentina: South & Central America Aesthetic Injectable Devices Market Share - by Product
    - 13.2.3.3.2 Argentina: South & Central America Aesthetic Injectable Devices Market Share - by Dermal Fillers
    - 13.2.3.3.3 Argentina: South & Central America Aesthetic Injectable Devices Market Share - by Device
    - 13.2.3.3.4 Argentina: South & Central America Aesthetic Injectable Devices Market Share - by Application
    - 13.2.3.3.5 Argentina: South & Central America Aesthetic Injectable Devices Market Share - by Age Group
    - 13.2.3.3.6 Argentina: South & Central America Aesthetic Injectable Devices Market Share - by Gender
    - 13.2.3.3.7 Argentina: South & Central America Aesthetic Injectable Devices Market Share - by End User
  - 13.3.4.4 Rest of South & Central America: South & Central America Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
    - 13.3.4.4.1 Rest of South & Central America: South & Central America Aesthetic Injectable Devices Market Share - by Product
    - 13.3.4.4.2 Rest of South & Central America: South & Central America Aesthetic Injectable Devices Market Share - by Dermal Fillers
    - 13.3.4.4.3 Rest of South & Central America: South & Central America Aesthetic Injectable Devices Market Share - by Device
    - 13.3.4.4.4 Rest of South & Central America: South & Central America Aesthetic Injectable Devices Market Share - by Application
    - 13.3.4.4.5 Rest of South & Central America: South & Central America Aesthetic Injectable Devices Market Share - by Age Group
    - 13.3.4.4.6 Rest of South & Central America: South & Central America Aesthetic Injectable Devices Market Share - by Gender
    - 13.3.4.4.7 Rest of South & Central America: South & Central America Aesthetic Injectable Devices Market Share - by End User

14 Competitive Landscape

14.1 Heat Map Analysis by Key Players
14.2 Company Positioning & Concentration

15 Industry Landscape

15.1 Overview
15.2 New Product Development
15.3 Merger and Acquisition
15.4 Other Strategic Developments

17 COMPANY PROFILES

16.1 Merz Pharma GmbH & Co KGaA
- 16.1.1 Key Facts
- 16.1.2 Business Description
- 16.1.3 Products and Services
- 16.1.4 Financial Overview
- 16.1.5 SWOT Analysis
- 16.1.6 Key Developments
16.2 AbbVie Inc
- 16.2.1 Key Facts
- 16.2.2 Business Description
- 16.2.3 Products and Services
- 16.2.4 Financial Overview
- 16.2.5 SWOT Analysis
- 16.2.6 Key Developments
16.3 Ipsen SA
- 16.3.1 Key Facts
- 16.3.2 Business Description
- 16.3.3 Products and Services
- 16.3.4 Financial Overview
- 16.3.5 SWOT Analysis
- 16.3.6 Key Developments
16.4 Mesoestetic E-Commerce SL
- 16.4.1 Key Facts
- 16.4.2 Business Description
- 16.4.3 Products and Services
- 16.4.4 Financial Overview
- 16.4.5 SWOT Analysis
- 16.4.6 Key Developments
16.5 Galderma SA
- 16.5.1 Key Facts
- 16.5.2 Business Description
- 16.5.3 Products and Services
- 16.5.4 Financial Overview
- 16.5.5 SWOT Analysis
- 16.5.6 Key Developments
16.6 Revance Therapeutics Inc
- 16.6.1 Key Facts
- 16.6.2 Business Description
- 16.6.3 Products and Services
- 16.6.4 Financial Overview
- 16.6.5 SWOT Analysis
- 16.6.6 Key Developments
16.7 Medytox Inc
- 16.7.1 Key Facts
- 16.7.2 Business Description
- 16.7.3 Products and Services
- 16.7.4 Financial Overview
- 16.7.5 SWOT Analysis
- 16.7.6 Key Developments
16.8 Sinopharm Group Co Ltd
- 16.8.1 Key Facts
- 16.8.2 Business Description
- 16.8.3 Products and Services
- 16.8.4 Financial Overview
- 16.8.5 SWOT Analysis
- 16.8.6 Key Developments
16.9 Evolus Inc
- 16.9.1 Key Facts
- 16.9.2 Business Description
- 16.9.3 Products and Services
- 16.9.4 Financial Overview
- 16.9.5 SWOT Analysis
- 16.9.6 Key Developments
16.10 Hugel Inc
- 16.10.1 Key Facts
- 16.10.2 Business Description
- 16.10.3 Products and Services
- 16.10.4 Financial Overview
- 16.10.5 SWOT Analysis
- 16.10.6 Key Developments
16.11 Sinclair Pharma Ltd
- 16.11.1 Key Facts
- 16.11.2 Business Description
- 16.11.3 Products and Services
- 16.11.4 Financial Overview
- 16.11.5 SWOT Analysis
- 16.11.6 Key Developments
16.12 Laboratoires Vivacy, S.A.S.
- 16.12.1 Key Facts
- 16.12.2 Business Description
- 16.12.3 Products and Services
- 16.12.4 Financial Overview
- 16.12.5 SWOT Analysis
- 16.12.6 Key Developments

17. Appendix

17.1 About The Insight Partners